Skip to main content
Visualsonic logo
Account
  • Login
Back
  • Products
    • Products
    • Imaging Systems
      • Vevo F2
      • Vevo F2 LAZR-X20
      • Vevo F2 LT
      • Vevo F2 LAZR-X
    • Transducers
      • Browse All Transducers
      • Vevo Optical Fibers and Jackets
    • Vevo LAB Analysis Suite
      • About Vevo LAB
      • Vevo CQ
      • Vevo Strain 2.0
      • Vevo Multiplexer
      • LV Analysis
      • Auto LV
      • Update your Vevo LAB Software
    • Imaging Modes Software
      • High-frequency Ultrasound Imaging
        • 4D-Mode
        • B-Mode
        • 3D-Mode
        • M-Mode
        • Anatomical M-Mode
        • Non-linear Contrast Mode
        • Power Doppler Mode
        • Pulsed-Wave Doppler Mode
        • Color Doppler Mode
        • Tissue Doppler Imaging
        • Digital RF-Mode
        • ECG and Respiration Gating
        • EKV
        • Shear Wave Elastography
      • Photoacoustic Imaging
        • Single Wavelength
        • Oxy-hemo
        • Spectro
        • Multi-wavelength
        • PA EKV
      • Acoustics & Engineering
        • VADA
    • Accessories
      • Vevo Imaging Station
      • Vevo Whole Body Imaging
      • Physiology Monitoring
      • Vevo Infusion Pump
      • Vevo PHANTOM
      • Vevo BRAIN
      • eBox
    • Contrast Agents
      • Photoacoustic Contrast Agents
        • About PA Contrast Agents
        • Angiostamp™800
      • Ultrasound Contrast Agents
        • Vevo MicroMarker
  • Applications
    • Applications
    • Preclinical
      • Oncology
      • Cardiology
      • Theranostics
      • Vascular Biology
      • Neurobiology
      • Developmental
      • Biomarker/Molecular Imaging
      • Image-guided Injection
      • Ischemia/Reperfusion
      • Drug Discovery and Development
      • Colorectal
      • Urogenital
      • Kidney
      • Liver
      • Fibrosis
      • Pulmonary
      • Pancreas
      • MSK
  • Resources
    • Resources
    • FAQ
    • Education
      • Learning Hub: Online Tutorials
      • Tips and Tricks
      • JoVE Videos
      • Request Training
      • Vevo University
    • News and Stories
      • Vevo News
      • Shared Stories
      • Vevo Blog
      • Research Spotlight
      • Case Studies
    • Grants & Fundings
      • Vevo International Student Awards
      • Grant Support
      • List of Grants & Funding
      • Funded Projects
    • Publications Library
    • Image Gallery
    • Recorded Webinars
    • On Demand Videos
  • Events
    • Events
    • Conferences and Society Meetings
    • Upcoming Webinars
    • Upcoming Workshops
  • Support
    • Support
    • Scientific Support
    • Technical Support
    • Vevo Service Plans
    • Request Training
    • FAQ
  • Our Company
    • Our Company
    • About Us
    • News
    • Our Technology
      • Our Technology
      • Ultra High-Frequency Ultrasound
      • Photoacoustics (PA)
    • Scientific Advisory Board
    • Patents
  • Contact
    • Contact
    • Contact Us
    • Our Global Offices
    • Maps and Directions
    • Distributors
  • Careers
    • Careers
    • Open Positions at VisualSonics
    • External Job Postings

Search

Publication
In humans, loss of central tolerance for the cardiac self-antigen α-myosin heavy chain (α-MHC) leads to circulation of cardiac autoreactive T cells and renders the heart susceptible to autoimmune attack after acute myocardial infarction (MI). MI triggers …
Read more
Publication
Aim: Imbalanced mitochondrial dynamics including suppressed mitochondrial fusion has been observed in diabetic hearts. However, it is still unknown whether mitochondrial fusion promoter is an effective protection to diabetic hearts. This study was …
Read more
Publication
Doxorubicin, as a first line chemotherapeutic agent, its usage is limited owing to cardiotoxicity. Necroptosis is a new form of programmed cell death, and recent investigations indicated that necroptosis is vitally involved in serious cardiac pathological …
Read more
Publication
Background Heart failure is one of the leading causes of death in Western countries, and there is a need for new therapeutic approaches. Relaxin-2 is a peptide hormone that mediates pleiotropic cardiovascular effects, including antifibrotic, angiogenic, …
Read more
Publication
Pathological cardiac hypertrophy (PCH) is characterized by an increase in cardiomyocyte size and thickening of the ventricular walls during the adaptive response to maintain cardiac function, which often progresses to a maladaptive response and, …
Read more
Publication
Salidroside (SAL) is the major ingredient of Rhodiola rosea, and has been traditionally used in Chinese medicine for decades. Numerous studies have demonstrated the protective effects of SAL for myocardial ischemia. However, it is yet to be deciphered …
Read more
Publication
Hereditary hemorrhagic telangiectasia (HHT) is an autosomal-dominant vascular disorder characterized by development of high-flow arteriovenous malformations (AVMs) that can lead to stroke or high-output heart failure. HHT2 is caused by heterozygous …
Read more
Publication
The chronic inflammatory microenvironment is characterized by the elevated level of reactive oxygen species (ROS). Here, it is hypothesized that developing an ROS‐scavenging scaffold loaded with rapamycin (Rapa@Gel) may offer a new strategy for modulating …
Read more
Publication
Accumulating evidence indicates that the onset of myocardial infarction (MI) shows obvious circadian rhythmicity. Clinical studies have shown that MIs that occur in the early morning have a poor prognosis, but the mechanisms involved are still unknown. In …
Read more
Publication
As new 2D layered nanomaterials, Bi2O2Se nanoplates have unique semiconducting properties that can benefit biomedical applications. Herein, a facile top-down approach for the synthesis of Bi2O2Se quantum dots (QDs) in a solution is described. The Bi2O2Se …
Read more

Pagination

  • First page « First
  • Previous page ‹‹
  • …
  • Page 116
  • Page 117
  • Page 118
  • Page 119
  • Current page 120
  • Page 121
  • Page 122
  • Page 123
  • Page 124
  • …
  • Next page ››
  • Last page Last »
  • Warranty and Service
  • Product Retirement
  • Security
  • Modern Slavery Act
  • Privacy
  • Terms of Service

Contact

Call us at: 1.866.416.4636 | Europe: +31 20 808 2913


VisualSonics, the VisualSonics logo, Vevo, Vevo MicroMarker and EKV are registered and unregistered trademarks of FUJIFILM Sonosite, Inc. in various jurisdictions. FUJIFILM is a registered trademark of FUJIFILM Corporation in various jurisdictions.

Copyright © 2025 FUJIFILM VisualSonics, Inc. All rights reserved. FUJIFILM VisualSonics, Inc is a subsidiary of FUJIFILM Sonosite, Inc.